G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024

G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day, and thank you for standing by. Welcome to the G1 Therapeutics First Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode. After the...